Literature DB >> 20087370

A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI.

Atle Bjørnerud1, Kyrre E Emblem.   

Abstract

Dynamic susceptibility contrast (DSC)-based perfusion analysis from MR images has become an established method for analysis of cerebral blood volume (CBV) in glioma patients. To date, little emphasis has, however, been placed on quantitative perfusion analysis of these patients, mainly due to the associated increased technical complexity and lack of sufficient stability in a clinical setting. The aim of our study was to develop a fully automated analysis framework for quantitative DSC-based perfusion analysis. The method presented here generates quantitative hemodynamic maps without user interaction, combined with automatic segmentation of normal-appearing cerebral tissue. Validation of 101 patients with confirmed glioma after surgery gave mean values for CBF, CBV, and MTT, extracted automatically from normal-appearing whole-brain white and gray matter, in good agreement with literature values. The measured age- and gender-related variations in the same parameters were also in agreement with those in the literature. Several established analysis methods were compared and the resulting perfusion metrics depended significantly on method and parameter choice. In conclusion, we present an accurate, fast, and automatic quantitative perfusion analysis method where all analysis steps are based on raw DSC data only.

Entities:  

Mesh:

Year:  2010        PMID: 20087370      PMCID: PMC2949177          DOI: 10.1038/jcbfm.2010.4

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

1.  Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging.

Authors:  Jussi Perkiö; Hannu J Aronen; Aki Kangasmäki; Yawu Liu; Jari Karonen; Sauli Savolainen; Leif Østergaard
Journal:  Magn Reson Med       Date:  2002-05       Impact factor: 4.668

2.  Quantification of bolus-tracking MRI: Improved characterization of the tissue residue function using Tikhonov regularization.

Authors:  Fernando Calamante; David G Gadian; Alan Connelly
Journal:  Magn Reson Med       Date:  2003-12       Impact factor: 4.668

3.  Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix.

Authors:  Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

4.  Aspects on the accuracy of cerebral perfusion parameters obtained by dynamic susceptibility contrast MRI: a simulation study.

Authors:  Linda Knutsson; Freddy Ståhlberg; Ronnie Wirestam
Journal:  Magn Reson Imaging       Date:  2004-07       Impact factor: 2.546

5.  Defining a local arterial input function for perfusion MRI using independent component analysis.

Authors:  Fernando Calamante; Morten Mørup; Lars Kai Hansen
Journal:  Magn Reson Med       Date:  2004-10       Impact factor: 4.668

6.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.

Authors:  K L Leenders; D Perani; A A Lammertsma; J D Heather; P Buckingham; M J Healy; J M Gibbs; R J Wise; J Hatazawa; S Herold
Journal:  Brain       Date:  1990-02       Impact factor: 13.501

7.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

Authors:  L Ostergaard; A G Sorensen; K K Kwong; R M Weisskoff; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

8.  Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.

Authors:  M Fuss; F Wenz; R Scholdei; M Essig; J Debus; M V Knopp; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

Review 9.  Dynamic magnetic resonance perfusion imaging of brain tumors.

Authors:  Diego J Covarrubias; Bruce R Rosen; Michael H Lev
Journal:  Oncologist       Date:  2004

10.  Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.

Authors:  K A Rempp; G Brix; F Wenz; C R Becker; F Gückel; W J Lorenz
Journal:  Radiology       Date:  1994-12       Impact factor: 11.105

View more
  52 in total

1.  Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.

Authors:  Elizabeth R Gerstner; Kyrre E Emblem; Ken Chang; Bella Vakulenko-Lagun; Yi-Fen Yen; Andrew L Beers; Jorg Dietrich; Scott R Plotkin; Ciprian Catana; Jacob M Hooker; Dan G Duda; Bruce Rosen; Jayashree Kalpathy-Cramer; Rakesh K Jain; Tracy Batchelor
Journal:  Clin Cancer Res       Date:  2019-09-26       Impact factor: 12.531

2.  Utilization of MR angiography in perfusion imaging for identifying arterial input function.

Authors:  Bora Buyuksarac; Mehmed Ozkan
Journal:  MAGMA       Date:  2017-07-25       Impact factor: 2.310

3.  Influence of blood/tissue differences in contrast agent relaxivity on tracer-based MR perfusion measurements.

Authors:  Arvid Morell; Fredrik Lennmyr; Ove Jonsson; Thomas Tovedal; Jean Pettersson; Jonas Bergquist; Vitas Zemgulis; Gunnar Myrdal Einarsson; Stefan Thelin; Håkan Ahlström; Atle Bjørnerud
Journal:  MAGMA       Date:  2014-06-28       Impact factor: 2.310

4.  Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans.

Authors:  Andreas Stadlbauer; Stefan Oberndorfer; Max Zimmermann; Bertold Renner; Michael Buchfelder; Gertraud Heinz; Arnd Doerfler; Andrea Kleindienst; Karl Roessler
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

5.  Cerebral blood volume mapping using Fourier-transform-based velocity-selective saturation pulse trains.

Authors:  Qin Qin; Yaoming Qu; Wenbo Li; Dapeng Liu; Taehoon Shin; Yansong Zhao; Doris D Lin; Peter C M van Zijl; Zhibo Wen
Journal:  Magn Reson Med       Date:  2019-02-08       Impact factor: 4.668

6.  Dynamic susceptibility contrast perfusion MRI using phase-based venous output functions: comparison with pseudo-continuous arterial spin labelling and assessment of contrast agent concentration in large veins.

Authors:  Ronnie Wirestam; Emelie Lind; André Ahlgren; Freddy Ståhlberg; Linda Knutsson
Journal:  MAGMA       Date:  2016-06-13       Impact factor: 2.310

7.  Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.

Authors:  Andreas Stadlbauer; Kim Mouridsen; Arnd Doerfler; Mikkel Bo Hansen; Stefan Oberndorfer; Max Zimmermann; Michael Buchfelder; Gertraud Heinz; Karl Roessler
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-24       Impact factor: 6.200

8.  Slice-accelerated gradient-echo echo planar imaging dynamic susceptibility contrast-enhanced MRI with blipped CAIPI: effect of increasing temporal resolution.

Authors:  Tomohiro Takamura; Masaaki Hori; Koji Kamagata; Kanako K Kumamaru; Ryusuke Irie; Akifumi Hagiwara; Nozomi Hamasaki; Shigeki Aoki
Journal:  Jpn J Radiol       Date:  2017-10-31       Impact factor: 2.374

9.  Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage.

Authors:  Cornelius Eichner; Kourosh Jafari-Khouzani; Stephen Cauley; Himanshu Bhat; Pavlina Polaskova; Ovidiu C Andronesi; Otto Rapalino; Robert Turner; Lawrence L Wald; Steven Stufflebeam; Kawin Setsompop
Journal:  Magn Reson Med       Date:  2013-10-28       Impact factor: 4.668

10.  Comparison of first pass bolus AIFs extracted from sequential 18F-FDG PET and DSC-MRI of mice.

Authors:  Eleanor Evans; Stephen J Sawiak; Alexander O Ward; Guido Buonincontri; Robert C Hawkes; T Adrian Carpenter
Journal:  Nucl Instrum Methods Phys Res A       Date:  2014-01-11       Impact factor: 1.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.